» Articles » PMID: 22970412

Neuropsychiatric Symptoms in Parkinson's Disease with Mild Cognitive Impairment and Dementia

Overview
Journal Parkinsons Dis
Publisher Wiley
Date 2012 Sep 13
PMID 22970412
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Neuropsychiatric symptoms commonly complicate Parkinson's disease (PD), however the presence of such symptoms in mild cognitive impairment (PD-MCI) specifically has not yet been well described. The objective of this study was to examine and compare the prevalence and profile of neuropsychiatric symptoms in patients with PD-MCI (n = 48) to those with PD and no cognitive impairment (PD-NC, n = 54) and to those with dementia in PD (PDD, n = 25). PD-MCI and PDD were defined using specific consensus criteria, and neuropsychiatric symptoms were assessed with the 12-item Neuropsychiatric Inventory (NPI). Self-rated apathy, depression, and anxiety rating scales were also administered. Over 79% of all participants reported at least one neuropsychiatric symptom in the past month. The proportion in each group who had total NPI scores of ≥4 ("clinically significant") was as follows: PD-NC, 64.8%; PD-MCI, 62%; PDD 76%. Apathy was reported in almost 50% of those with PD-MCI and PDD, and it was an important neuropsychiatric symptom differentiating PD-MCI from PD-NC. Psychosis (hallucinations and delusions) increased from 12.9% in PD-NC group; 16.7% in PD-MCI group; and 48% in PDD group. Identifying neuropsychiatric symptoms in PD-MCI may have implications for ascertaining conversion to dementia in PD.

Citing Articles

Plasma phosphorylated tau and neuropsychiatric symptoms in dementia with Lewy bodies.

Gibson L, Gonzalez M, Ashton N, Tovar-Rios D, Blanc F, Pilotto A Alzheimers Dement. 2024; 21(2):e14434.

PMID: 39732510 PMC: 11848415. DOI: 10.1002/alz.14434.


Cognitive disorders in advanced Parkinson's disease: challenges in the diagnosis of delirium.

Daniels C, Rodriguez-Antiguedad J, Jentschke E, Kulisevsky J, Volkmann J Neurol Res Pract. 2024; 6(1):14.

PMID: 38481336 PMC: 10938698. DOI: 10.1186/s42466-024-00309-4.


Mild Behavioral Impairment in Parkinson's Disease: An Updated Review on the Clinical, Genetic, Neuroanatomical, and Pathophysiological Aspects.

Angelopoulou E, Bougea A, Hatzimanolis A, Stefanis L, Scarmeas N, Papageorgiou S Medicina (Kaunas). 2024; 60(1).

PMID: 38256375 PMC: 10820007. DOI: 10.3390/medicina60010115.


Anxiety, Depression, and Apathy as Predictors of Cognitive Decline in Patients With Parkinson's Disease-A Three-Year Follow-Up Study.

Toloraia K, Meyer A, Beltrani S, Fuhr P, Lieb R, Gschwandtner U Front Neurol. 2022; 13:792830.

PMID: 35211081 PMC: 8860828. DOI: 10.3389/fneur.2022.792830.


Table tennis for patients with Parkinson's disease: A single-center, prospective pilot study.

Inoue K, Fujioka S, Nagaki K, Suenaga M, Kimura K, Yonekura Y Clin Park Relat Disord. 2021; 4:100086.

PMID: 34316664 PMC: 8299968. DOI: 10.1016/j.prdoa.2020.100086.


References
1.
Dubois B, Burn D, Goetz C, Aarsland D, Brown R, Broe G . Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord. 2007; 22(16):2314-24. DOI: 10.1002/mds.21844. View

2.
Aarsland D, Cummings J, Larsen J . Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease. Int J Geriatr Psychiatry. 2001; 16(2):184-91. DOI: 10.1002/1099-1166(200102)16:2<184::aid-gps304>3.0.co;2-k. View

3.
Poewe W . Psychosis in Parkinson's disease. Mov Disord. 2003; 18 Suppl 6:S80-7. DOI: 10.1002/mds.10567. View

4.
Czernecki V, Pillon B, Houeto J, Pochon J, Levy R, Dubois B . Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia. 2002; 40(13):2257-67. DOI: 10.1016/s0028-3932(02)00108-2. View

5.
Starkstein S, Ingram L, Garau M, Mizrahi R . On the overlap between apathy and depression in dementia. J Neurol Neurosurg Psychiatry. 2005; 76(8):1070-4. PMC: 1739766. DOI: 10.1136/jnnp.2004.052795. View